Global Nicotinamide Mononucleotide NMN Market Research Report 2023(Status and Outlook)
Report Overview
The Nicotinamide Mononucleotide (NMN) market covers Content ＜98%, Content ≥98%, etc. The typical players include GeneHarbor, Herbalmax, Genex Formulas, Shinkowa Pharmaceutical, Maac10 Formulas, etc. Nicotinamide mononucleotide is a nucleotide derived from ribose and nicotinamide. NMN is made from B vitamins in the body, and is a molecule naturally occurring in all life forms.
The Global Nicotinamide Mononucleotide NMN Market Size was estimated at USD 280.20 million in 2022 and is projected to reach USD 546.03 million by 2029, exhibiting a CAGR of 10.00% during the forecast period.
Bosson Research’s latest report provides a deep insight into the global Nicotinamide Mononucleotide NMN market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, Porter’s five forces analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Nicotinamide Mononucleotide NMN Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Nicotinamide Mononucleotide NMN market in any manner.
Global Nicotinamide Mononucleotide NMN Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
GeneHarbor
Herbalmax
Genex Formulas
Shinkowa Pharmaceutical
Maac10 Formulas
EffePharm
Bontac
CELFULL
Kingdomway
Market Segmentation (by Type)
Content below 98%
Content above 98%
Market Segmentation (by Application)
Passenger Vehicle
Commercial Vehicle
Geographic Segmentation
North America (USA, Canada, Mexico)
Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
South America (Brazil, Argentina, Columbia, Rest of South America)
The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
Key Benefits of This Market Research:
Industry drivers, restraints, and opportunities covered in the study
Neutral perspective on the market performance
Recent industry trends and developments
Competitive landscape & strategies of key players
Potential & niche segments and regions exhibiting promising growth covered
Historical, current, and projected market size, in terms of value
In-depth analysis of the Nicotinamide Mononucleotide NMN Market
Overview of the regional outlook of the Nicotinamide Mononucleotide NMN Market:
Key Reasons to Buy this Report:
Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
This enables you to anticipate market changes to remain ahead of your competitors
- 1 Research Methodology and Statistical Scope
- 1.1 Market Definition and Statistical Scope of Nicotinamide Mononucleotide NMN
- 1.2 Key Market Segments
- 1.2.1 Nicotinamide Mononucleotide NMN Segment by Type
- 1.2.2 Nicotinamide Mononucleotide NMN Segment by Application
- 1.3 Methodology & Sources of Information
- 1.3.1 Research Methodology
- 1.3.2 Research Process
- 1.3.3 Market Breakdown and Data Triangulation
- 1.3.4 Base Year
- 1.3.5 Report Assumptions & Caveats
- 2 Nicotinamide Mononucleotide NMN Market Overview
- 2.1 Global Market Overview
- 2.1.1 Global Nicotinamide Mononucleotide NMN Market Size (M USD) Estimates and Forecasts (2018-2029)
- 2.1.2 Global Nicotinamide Mononucleotide NMN Sales Estimates and Forecasts (2018-2029)
- 2.2 Market Segment Executive Summary
- 2.3 Global Market Size by Region
- 3 Nicotinamide Mononucleotide NMN Market Competitive Landscape
- 3.1 Global Nicotinamide Mononucleotide NMN Sales by Manufacturers (2018-2023)
- 3.2 Global Nicotinamide Mononucleotide NMN Revenue Market Share by Manufacturers (2018-2023)
- 3.3 Nicotinamide Mononucleotide NMN Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
- 3.4 Global Nicotinamide Mononucleotide NMN Average Price by Manufacturers (2018-2023)
- 3.5 Manufacturers Nicotinamide Mononucleotide NMN Sales Sites, Area Served, Product Type
- 3.6 Nicotinamide Mononucleotide NMN Market Competitive Situation and Trends
- 3.6.1 Nicotinamide Mononucleotide NMN Market Concentration Rate
- 3.6.2 Global 5 and 10 Largest Nicotinamide Mononucleotide NMN Players Market Share by Revenue
- 3.6.3 Mergers & Acquisitions, Expansion
- 4 Nicotinamide Mononucleotide NMN Industry Chain Analysis
- 4.1 Nicotinamide Mononucleotide NMN Industry Chain Analysis
- 4.2 Market Overview of Key Raw Materials
- 4.3 Midstream Market Analysis
- 4.4 Downstream Customer Analysis
- 5 The Development and Dynamics of Nicotinamide Mononucleotide NMN Market
- 5.1 Key Development Trends
- 5.2 Driving Factors
- 5.3 Market Challenges
- 5.4 Market Restraints
- 5.5 Industry News
- 5.5.1 New Product Developments
- 5.5.2 Mergers & Acquisitions
- 5.5.3 Expansions
- 5.5.4 Collaboration/Supply Contracts
- 5.6 Industry Policies
- 6 Nicotinamide Mononucleotide NMN Market Segmentation by Type
- 6.1 Evaluation Matrix of Segment Market Development Potential (Type)
- 6.2 Global Nicotinamide Mononucleotide NMN Sales Market Share by Type (2018-2023)
- 6.3 Global Nicotinamide Mononucleotide NMN Market Size Market Share by Type (2018-2023)
- 6.4 Global Nicotinamide Mononucleotide NMN Price by Type (2018-2023)
- 7 Nicotinamide Mononucleotide NMN Market Segmentation by Application
- 7.1 Evaluation Matrix of Segment Market Development Potential (Application)
- 7.2 Global Nicotinamide Mononucleotide NMN Market Sales by Application (2018-2023)
- 7.3 Global Nicotinamide Mononucleotide NMN Market Size (M USD) by Application (2018-2023)
- 7.4 Global Nicotinamide Mononucleotide NMN Sales Growth Rate by Application (2018-2023)
- 8 Nicotinamide Mononucleotide NMN Market Segmentation by Region
- 8.1 Global Nicotinamide Mononucleotide NMN Sales by Region
- 8.1.1 Global Nicotinamide Mononucleotide NMN Sales by Region
- 8.1.2 Global Nicotinamide Mononucleotide NMN Sales Market Share by Region
- 8.2 North America
- 8.2.1 North America Nicotinamide Mononucleotide NMN Sales by Country
- 8.2.2 U.S.
- 8.2.3 Canada
- 8.2.4 Mexico
- 8.3 Europe
- 8.3.1 Europe Nicotinamide Mononucleotide NMN Sales by Country
- 8.3.2 Germany
- 8.3.3 France
- 8.3.4 U.K.
- 8.3.5 Italy
- 8.3.6 Russia
- 8.4 Asia Pacific
- 8.4.1 Asia Pacific Nicotinamide Mononucleotide NMN Sales by Region
- 8.4.2 China
- 8.4.3 Japan
- 8.4.4 South Korea
- 8.4.5 India
- 8.4.6 Southeast Asia
- 8.5 South America
- 8.5.1 South America Nicotinamide Mononucleotide NMN Sales by Country
- 8.5.2 Brazil
- 8.5.3 Argentina
- 8.5.4 Columbia
- 8.6 Middle East and Africa
- 8.6.1 Middle East and Africa Nicotinamide Mononucleotide NMN Sales by Region
- 8.6.2 Saudi Arabia
- 8.6.3 UAE
- 8.6.4 Egypt
- 8.6.5 Nigeria
- 8.6.6 South Africa
- 9 Key Companies Profile
- 9.1 GeneHarbor
- 9.1.1 GeneHarbor Nicotinamide Mononucleotide NMN Basic Information
- 9.1.2 GeneHarbor Nicotinamide Mononucleotide NMN Product Overview
- 9.1.3 GeneHarbor Nicotinamide Mononucleotide NMN Product Market Performance
- 9.1.4 GeneHarbor Business Overview
- 9.1.5 GeneHarbor Nicotinamide Mononucleotide NMN SWOT Analysis
- 9.1.6 GeneHarbor Recent Developments
- 9.2 Herbalmax
- 9.2.1 Herbalmax Nicotinamide Mononucleotide NMN Basic Information
- 9.2.2 Herbalmax Nicotinamide Mononucleotide NMN Product Overview
- 9.2.3 Herbalmax Nicotinamide Mononucleotide NMN Product Market Performance
- 9.2.4 Herbalmax Business Overview
- 9.2.5 Herbalmax Nicotinamide Mononucleotide NMN SWOT Analysis
- 9.2.6 Herbalmax Recent Developments
- 9.3 Genex Formulas
- 9.3.1 Genex Formulas Nicotinamide Mononucleotide NMN Basic Information
- 9.3.2 Genex Formulas Nicotinamide Mononucleotide NMN Product Overview
- 9.3.3 Genex Formulas Nicotinamide Mononucleotide NMN Product Market Performance
- 9.3.4 Genex Formulas Business Overview
- 9.3.5 Genex Formulas Nicotinamide Mononucleotide NMN SWOT Analysis
- 9.3.6 Genex Formulas Recent Developments
- 9.4 Shinkowa Pharmaceutical
- 9.4.1 Shinkowa Pharmaceutical Nicotinamide Mononucleotide NMN Basic Information
- 9.4.2 Shinkowa Pharmaceutical Nicotinamide Mononucleotide NMN Product Overview
- 9.4.3 Shinkowa Pharmaceutical Nicotinamide Mononucleotide NMN Product Market Performance
- 9.4.4 Shinkowa Pharmaceutical Business Overview
- 9.4.5 Shinkowa Pharmaceutical Nicotinamide Mononucleotide NMN SWOT Analysis
- 9.4.6 Shinkowa Pharmaceutical Recent Developments
- 9.5 Maac10 Formulas
- 9.5.1 Maac10 Formulas Nicotinamide Mononucleotide NMN Basic Information
- 9.5.2 Maac10 Formulas Nicotinamide Mononucleotide NMN Product Overview
- 9.5.3 Maac10 Formulas Nicotinamide Mononucleotide NMN Product Market Performance
- 9.5.4 Maac10 Formulas Business Overview
- 9.5.5 Maac10 Formulas Nicotinamide Mononucleotide NMN SWOT Analysis
- 9.5.6 Maac10 Formulas Recent Developments
- 9.6 EffePharm
- 9.6.1 EffePharm Nicotinamide Mononucleotide NMN Basic Information
- 9.6.2 EffePharm Nicotinamide Mononucleotide NMN Product Overview
- 9.6.3 EffePharm Nicotinamide Mononucleotide NMN Product Market Performance
- 9.6.4 EffePharm Business Overview
- 9.6.5 EffePharm Recent Developments
- 9.7 Bontac
- 9.7.1 Bontac Nicotinamide Mononucleotide NMN Basic Information
- 9.7.2 Bontac Nicotinamide Mononucleotide NMN Product Overview
- 9.7.3 Bontac Nicotinamide Mononucleotide NMN Product Market Performance
- 9.7.4 Bontac Business Overview
- 9.7.5 Bontac Recent Developments
- 9.8 CELFULL
- 9.8.1 CELFULL Nicotinamide Mononucleotide NMN Basic Information
- 9.8.2 CELFULL Nicotinamide Mononucleotide NMN Product Overview
- 9.8.3 CELFULL Nicotinamide Mononucleotide NMN Product Market Performance
- 9.8.4 CELFULL Business Overview
- 9.8.5 CELFULL Recent Developments
- 9.9 Kingdomway
- 9.9.1 Kingdomway Nicotinamide Mononucleotide NMN Basic Information
- 9.9.2 Kingdomway Nicotinamide Mononucleotide NMN Product Overview
- 9.9.3 Kingdomway Nicotinamide Mononucleotide NMN Product Market Performance
- 9.9.4 Kingdomway Business Overview
- 9.9.5 Kingdomway Recent Developments
- 10 Nicotinamide Mononucleotide NMN Market Forecast by Region
- 10.1 Global Nicotinamide Mononucleotide NMN Market Size Forecast
- 10.2 Global Nicotinamide Mononucleotide NMN Market Forecast by Region
- 10.2.1 North America Market Size Forecast by Country
- 10.2.2 Europe Nicotinamide Mononucleotide NMN Market Size Forecast by Country
- 10.2.3 Asia Pacific Nicotinamide Mononucleotide NMN Market Size Forecast by Region
- 10.2.4 South America Nicotinamide Mononucleotide NMN Market Size Forecast by Country
- 10.2.5 Middle East and Africa Forecasted Consumption of Nicotinamide Mononucleotide NMN by Country
- 11 Forecast Market by Type and by Application (2024-2029)
- 11.1 Global Nicotinamide Mononucleotide NMN Market Forecast by Type (2024-2029)
- 11.1.1 Global Forecasted Sales of Nicotinamide Mononucleotide NMN by Type (2024-2029)
- 11.1.2 Global Nicotinamide Mononucleotide NMN Market Size Forecast by Type (2024-2029)
- 11.1.3 Global Forecasted Price of Nicotinamide Mononucleotide NMN by Type (2024-2029)
- 11.2 Global Nicotinamide Mononucleotide NMN Market Forecast by Application (2024-2029)
- 11.2.1 Global Nicotinamide Mononucleotide NMN Sales (K MT) Forecast by Application
- 11.2.2 Global Nicotinamide Mononucleotide NMN Market Size (M USD) Forecast by Application (2024-2029)
- 12 Conclusion and Key Findings
Research Assistance
Download our eBook: How to Succeed Using Market Research
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook